SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Chemfab Alkalis Ltd (CHEMFAB)

Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 541269 NSE: CHEMFAB Chemicals | Small Cap | Chemfab Alkalis Share Price

₹409 15.70 (3.99%)

As on 04-Jun'26 16:59

Chemfab Alkalis Ltd (CHEMFAB)

Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 541269 NSE: CHEMFAB Chemicals | Small Cap | Chemfab Alkalis Share Price

₹409 15.70 (3.99%)

As on 04-Jun'26 16:59

Key Metrics
Valuation Multiples
Market Cap
₹588 Cr.
Current Price
₹409
52-Week Low / High
₹270 / 846
TTM EPS
₹5.2
TTM Sales
₹289 Cr.
Book Value per Share
₹288.1
P/E Ratio
78.33
Higher than its 5-year historical median
Industry PE
50.2
Price to Book (P/B)
1.42
In line with its 5-year historical median
Price to Sales (P/S)
2.04
Higher than its 5-year historical median
EV/EBITDA
16.63
Higher than its 5-year historical median
Dividend Yield
0.18%
Profitability Efficiency
Return on Equity (ROE)
3.81%
Return on Capital Employed (ROCE)
6.05%
Return on Assets (ROA)
2.72%
Operating Profit Margin
16.7%
Net Profit Margin
4.73%
Gross Profit Margin
16.7%
Growth Momentum
1-yr vs 3-yr growth
Sales Growth (1 Year)
Slowing versus 3-year growth rate
-1.59%
Operating Profit Growth (1 Year)
Slowing versus 3-year growth rate
-6.77%
Net Profit Growth (1 Year)
Slowing versus 3-year growth rate
-49.25%
Asset Quality
Promoter Holding
72.13%
Pledged shares (%) of Promoter's holding (%)
0.00%
Reserves
₹400 Cr.
Equity
₹14.4 Cr.
Face Value
₹10
All Time Low / High
₹90.05 / 1229.50

Chemfab Alkalis stock performance

Key Ratios
mw4me loader

Check Before You Invest

Quality

Somewhat Good

Valuation

Fair

Price Trend

Semi Strong
Q.1 Is Chemfab Alkalis Ltd a good quality company?
Chemfab Alkalis Ltd is a average quality company, based on a somewhat consistent multi-year financial track record.

This assessment is based on company’s performance on Revenue growth, ROCE, Equity and Assets, key margin ratios, cash conversion cycle, and debt to cash flow from operations and how it compares with its long term averages.

We have analysed the performance of the company on the following:

  • How has it performed on generating Profits?

    By checking its Revenue growth, Gross, Operating and Net Margins compared to its last 5-year median.

  • How efficiently has it utilized Capital?

    By checking its ROCE, ROA, ROE and its Cash Conversion Cycle.

  • How is it managing its Debt?

    By checking its Debt to Equity and Cash Flow from Operations.

How does Chemfab Alkalis Ltd performance compare with that of its Peers?
Q.1 Revenue growth of Chemfab Alkalis Ltd vs industry peers?
Chemfab Alkalis Ltd revenue CAGR is 9.51%, compared to the industry median CAGR of 7.53%, indicating faster growth and gaining its market share.
Q.1 Promoter shareholding and pledge status of Chemfab Alkalis Ltd?
Promoters hold 72.13% of the Chemfab Alkalis Ltd, with 0.00% of their stake pledged, indicating no pledge risk.
Q.1 Stock return of Chemfab Alkalis Ltd over the last decade?
Over the last 5 year(s), the stock has delivered a CAGR of 20.63% based on the current price.

10 Year X-Ray :

Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Chemfab Alkalis Ltd has performed well in some of the past ten years indicating its past ten year financial track record is somewhat good

Value Creation

Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25TTM
ROCE % 9.3%17.7%11.4%10.1%1.6%13.4%27.4%11.4%6.1%-
Value Creation
Index
-0.30.3-0.2-0.3-0.9-0.11.0-0.2-0.6-

Growth Parameters

Sales 140180193205181272331327322289
Sales YoY Gr.-28.1%7.6%5.8%-11.6%50.2%22%-1.2%-1.6%-
Adj EPS 11.318.121.920-5.520.348.220.99.85.2
YoY Gr.-59.3%21.4%-8.9%-127.5%NA137.7%-56.7%-53.3%-
BVPS (₹) 155.4170.6180.5197.6189.9210.4255.2275283.7288.1
Adj Net
Profit
15.72530.427.8-7.728.768.429.7148
Cash Flow from Ops. 37.944.6415445.655.296.952.160.9-
Debt/CF from Ops. 0.40.50.80.80.70.100.41.4-

CAGR

9 Years 5 Years 3 Years 1 Years
Sales NA9.5%5.9%-1.6%
Adj EPS NA-13.3%-21.7%-53.3%
BVPSNA7.5%10.5%3.2%
Share Price - 22.7% 7.4% -46.1%

Key Financial Parameters

Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25TTM
Return on
Equity %
7.311.112.510.6-2.910.120.77.93.51.8
Op. Profit
Mgn %
22.928.931.727.313.420.933.917.616.711.9
Net Profit
Mgn %
11.213.915.713.6-4.310.620.69.14.42.6
Debt to
Equity
0.10.10.10.20.1000.10.20.2
Working Cap
Days
017317717518011510914717446
Cash Conv.
Cycle
0-112648269-32

Profit And Loss

(All Figures are in Crores.)
PARTICULARSMar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Sales140180193205181272331327322
Operating Expenses + 109128133149157215219270268
Manufacturing Costs749081787997107126134
Material Costs7520374380709886
Employee Cost 151516181820192223
Other Costs 131815161618242426
Operating Profit 3252615624571125854
Operating Profit Margin (%) 22.6%28.7%31.4%27.2%13.1%20.9%33.9%17.6%16.7%
Other Income + 345316586
Exceptional Items 00-20-300-300
Interest 532431115
Depreciation 131215252022232232
Profit Before Tax 17402827239914322
Tax 114121101025137
Profit After Tax 16251726-829663015
PAT Margin (%) 11.1%14.2%8.7%12.5%-4.5%10.6%20.0%9.2%4.7%
Adjusted EPS (₹)11.218.412.118.4-5.720.446.721.110.6
Dividend Payout Ratio (%)7.40%6.80%10.40%6.80%0%6.10%2.70%5.90%11.80%

Valuation of Chemfab Alkalis - Standalone

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

mw4me loader

Analyst's Notes

data not found
No data found!

Balance Sheet

(All Figures are in Crores.)
PARTICULARSMar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25

Equity and Liabilities

Shareholders Fund + 215236251275267297362391407
Share Capital 141414141414141414
Reserves 201222237261253283348377393
Debt +1623283624701666
Long Term Debt169282223001664
Short Term Debt01401407002
Minority Interest000000000
Trade Payables131812171820282731
Others Liabilities 21-31891325449883
Total Liabilities 265273309337322349434532587

Fixed Assets

Net Fixed Assets +164173194195202194191181249
Gross Block177198253286274277288297395
Accumulated Depreciation13256091728397116146
CWIP 112103537145712
Investments 00083142110110164
Inventories4389912171523
Trade Receivables81716101521222120
Cash Equivalents 21243384245
Others Assets 75667678586576124115
Total Assets 265273309337322349434532587

Cash Flow

(All Figures are in Crores.)
PARTICULARSMar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Cash Flow From Operating Activity + 384441544655975261
PBT 16251727239914322
Adjustment 192846332724221735
Changes in Working Capital 2-1-1108-2-1210
Tax Paid 1-8-11-78-6-14-9-6
Cash Flow From Investing Activity + -9-30-47-58-7-21-52-130-107
Capex -8-25-52-50-7-16-26-50-88
Net Investments -0-65000000
Others -111-71-5-26-81-19
Cash Flow From Financing Activity + -30-1363-16-25-91659
Net Proceeds from Shares 000011111
Net Proceeds from Borrowing 000000000
Interest Paid -2-2-5-3-3-1-0-1-5
Dividend Paid -1-2-2-2-2-0-2-2-2
Others -27-10128-12-24-71864
Net Cash Flow -110-123936-6213

Financial Ratio

PARTICULARSMar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Ratios
ROE (%)7.2211.316.899.73-2.9710.2220.097.963.81
ROCE (%)9.2617.6611.3810.091.5913.3627.3811.366.05
Asset Turnover Ratio0.590.680.660.630.550.810.850.680.58
PAT to CFO Conversion(x)2.381.762.412.08N/A1.91.471.734.07
Working Capital Days
Receivable Days19.7025.3031.6023.1024.9024.6023.7023.9023.30
Inventory Days107.5010.9014.901814.2015.801821.70
Payable Days683.701,136.60279.90142.4014786.90125.20101.90124.10

Management X-Ray

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged *0.000.000.000.000.000.000.000.000.000.00
* Pledged shares as % of Promoter's holding (%)

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

Chemfab Alkalis Ltd FAQs

The current trading price of Chemfab Alkalis on 04-Jun-2026 16:59 is ₹409.0.

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 03-Jun-2026 the market cap of Chemfab Alkalis stood at ₹587.9 Cr

The latest P/E ratio of Chemfab Alkalis as of 03-Jun-2026 is 78.33.

The latest P/B ratio of Chemfab Alkalis as of 03-Jun-2026 is 1.42.

The 52-week high of Chemfab Alkalis is ₹845.6 and the 52-week low is ₹270.0.

The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Chemfab Alkalis is ₹289 ( Cr.) .

Past 10 year's financial track record analysis by Moneyworks4me indicates that Chemfab Alkalis Ltd is a average quality company.

The key valuation ratios of Chemfab Alkalis Ltd's currently when compared to its past seem to suggest it is in the Fair zone.

The Price Trend analysis by MoneyWorks4Me indicates it is Semi Strong which suggest that the price of Chemfab Alkalis Ltd is likely to Rise-somewhat in the short term. However, please check the rating on Quality and Valuation before investing.

About Chemfab Alkalis Ltd

No data to display
You have 1 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×